Trial Outcomes & Findings for OSA Screen Negative With Spinal Duramorph (NCT NCT03151226)

NCT ID: NCT03151226

Last Updated: 2018-09-07

Results Overview

defined by values obtained utilizing capnography and pulse oximetry

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

3 participants

Primary outcome timeframe

up to 24 hours

Results posted on

2018-09-07

Participant Flow

Participant milestones

Participant milestones
Measure
Capnography Monitoring
single arm, all subjects receiving duramorph will receive capnography monitoring Capnography monitoring: capnography and pulse oximetry will be initiated in the recovery room and worn for 12-24 hours post delivery
Overall Study
STARTED
3
Overall Study
COMPLETED
0
Overall Study
NOT COMPLETED
3

Reasons for withdrawal

Reasons for withdrawal
Measure
Capnography Monitoring
single arm, all subjects receiving duramorph will receive capnography monitoring Capnography monitoring: capnography and pulse oximetry will be initiated in the recovery room and worn for 12-24 hours post delivery
Overall Study
Withdrawal by Subject
2
Overall Study
not wear device correctly
1

Baseline Characteristics

OSA Screen Negative With Spinal Duramorph

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Capnography Monitoring
n=3 Participants
single arm, all subjects receiving duramorph will receive capnography monitoring Capnography monitoring: capnography and pulse oximetry will be initiated in the recovery room and worn for 12-24 hours post delivery
Age, Categorical
<=18 years
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
3 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
Sex: Female, Male
Female
3 Participants
n=5 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
1 Participants
n=5 Participants
Race (NIH/OMB)
White
2 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
Region of Enrollment
United States
3 Participants
n=5 Participants

PRIMARY outcome

Timeframe: up to 24 hours

Population: the 2 subjects who wore device did not wear the device enough to be evaluable data

defined by values obtained utilizing capnography and pulse oximetry

Outcome measures

Outcome data not reported

Adverse Events

Capnography Monitoring

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Peter H. Pan

Wake Forest School of Medicine

Phone: 336-718-8278

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place